Page last updated: 2024-10-29

indirubin-3'-monoxime and Disease Models, Animal

indirubin-3'-monoxime has been researched along with Disease Models, Animal in 8 studies

indirubin-3'-monoxime: has antiangiogenic activity
indirubin-3'-monoxime : A member of the class of biindoles that is indirubin in which the keto group at position 3' has undergone condensation with hydroxylamine to form the corresponding oxime.

Disease Models, Animal: Naturally-occurring or experimentally-induced animal diseases with pathological processes analogous to human diseases.

Research Excerpts

ExcerptRelevanceReference
"Using an oral cancer mouse model, we demonstrate that topical application of an adhesive gel composed of I3M and poly(vinyl alcohol) (I3M/PVA) has dose-dependent anti-tumorigenic effects."1.39An indirubin derivative, indirubin-3'-monoxime suppresses oral cancer tumorigenesis through the downregulation of survivin. ( Chang, NW; Lo, WY, 2013)

Research

Studies (8)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (12.50)29.6817
2010's5 (62.50)24.3611
2020's2 (25.00)2.80

Authors

AuthorsStudies
Solinski, HJ1
Dranchak, P1
Oliphant, E1
Gu, X1
Earnest, TW1
Braisted, J1
Inglese, J1
Hoon, MA1
Abrams, RPM1
Yasgar, A1
Teramoto, T1
Lee, MH1
Dorjsuren, D1
Eastman, RT1
Malik, N1
Zakharov, AV1
Li, W2
Bachani, M1
Brimacombe, K1
Steiner, JP1
Hall, MD1
Balasubramanian, A1
Jadhav, A1
Padmanabhan, R1
Simeonov, A1
Nath, A1
Dera, AA1
Rajagopalan, P1
Al Fayi, M1
Ahmed, I1
Chandramoorthy, HC1
Sathiya Priya, C1
Vidhya, R1
Kalpana, K1
Anuradha, CV1
Lo, WY1
Chang, NW1
Ding, Y1
Qiao, A1
Fan, GH1
Schwaiberger, AV1
Heiss, EH1
Cabaravdic, M1
Oberan, T1
Zaujec, J1
Schachner, D1
Uhrin, P1
Atanasov, AG1
Breuss, JM1
Binder, BR1
Dirsch, VM1
Wang, W1
Yang, Y1
Ying, C1
Ruan, H1
Zhu, X1
You, Y1
Han, Y1
Chen, R1
Wang, Y1
Li, M1

Other Studies

8 other studies available for indirubin-3'-monoxime and Disease Models, Animal

ArticleYear
Inhibition of natriuretic peptide receptor 1 reduces itch in mice.
    Science translational medicine, 2019, 07-10, Volume: 11, Issue:500

    Topics: Animals; Behavior, Animal; Cell-Free System; Dermatitis, Contact; Disease Models, Animal; Ganglia, S

2019
Therapeutic candidates for the Zika virus identified by a high-throughput screen for Zika protease inhibitors.
    Proceedings of the National Academy of Sciences of the United States of America, 2020, 12-08, Volume: 117, Issue:49

    Topics: Animals; Antiviral Agents; Artificial Intelligence; Chlorocebus aethiops; Disease Models, Animal; Dr

2020
Indirubin-3-monoxime and thymoquinone exhibit synergistic efficacy as therapeutic combination in in-vitro and in-vivo models of Lung cancer.
    Archives of pharmacal research, 2020, Volume: 43, Issue:6

    Topics: A549 Cells; Animals; Antineoplastic Agents; Apoptosis; Benzoquinones; Cell Cycle; Cell Line; Cell Pr

2020
Indirubin-3'-monoxime prevents aberrant activation of GSK-3β/NF-κB and alleviates high fat-high fructose induced Aβ-aggregation, gliosis and apoptosis in mice brain.
    International immunopharmacology, 2019, Volume: 70

    Topics: Amyloid beta-Peptides; Animals; Apoptosis; Brain; Diet, High-Fat; Disease Models, Animal; Fructose;

2019
An indirubin derivative, indirubin-3'-monoxime suppresses oral cancer tumorigenesis through the downregulation of survivin.
    PloS one, 2013, Volume: 8, Issue:8

    Topics: Animals; Antineoplastic Agents; Apoptosis; Cell Cycle Checkpoints; Cell Line, Tumor; Cell Movement;

2013
Indirubin-3'-monoxime rescues spatial memory deficits and attenuates beta-amyloid-associated neuropathology in a mouse model of Alzheimer's disease.
    Neurobiology of disease, 2010, Volume: 39, Issue:2

    Topics: Alzheimer Disease; Amyloid beta-Peptides; Amyloid beta-Protein Precursor; Analysis of Variance; Anim

2010
Indirubin-3'-monoxime blocks vascular smooth muscle cell proliferation by inhibition of signal transducer and activator of transcription 3 signaling and reduces neointima formation in vivo.
    Arteriosclerosis, thrombosis, and vascular biology, 2010, Volume: 30, Issue:12

    Topics: Animals; Arterial Occlusive Diseases; Becaplermin; Cell Cycle; Cell Proliferation; Cells, Cultured;

2010
Inhibition of glycogen synthase kinase-3beta protects dopaminergic neurons from MPTP toxicity.
    Neuropharmacology, 2007, Volume: 52, Issue:8

    Topics: Analysis of Variance; Animals; Apoptosis; Corpus Striatum; Disease Models, Animal; Dopamine; Dose-Re

2007